New capacities of the diagnosis and monitoring of the course of AL-amyloidosis

Aim: to define the clinical value of various concentrations of immunoglobulin light chains (ILCs) in patients with AL amyloidosis. Subjects and methods. The content of free ILCs was studied by a nephelometric technique after their fixation in the blood of 31 patients with AL amyloidosis; monoclonal...

Full description

Bibliographic Details
Main Authors: V V Rameyev, L V Kozlovskaya, I N Kogarko, B S Kogarko
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2010-06-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30597
id doaj-47ce9473f6734c619e70f03583ea918f
record_format Article
spelling doaj-47ce9473f6734c619e70f03583ea918f2020-11-25T03:12:26Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422010-06-01826293227624New capacities of the diagnosis and monitoring of the course of AL-amyloidosisV V Rameyev0L V Kozlovskaya1I N Kogarko2B S Kogarko3I. M. Sechenov Moscow MedicalI. M. Sechenov Moscow MedicalResearch Center, I. M. Sechenov Moscow Medical AcademyN. N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, MoscowN. N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, MoscowAim: to define the clinical value of various concentrations of immunoglobulin light chains (ILCs) in patients with AL amyloidosis. Subjects and methods. The content of free ILCs was studied by a nephelometric technique after their fixation in the blood of 31 patients with AL amyloidosis; monoclonal gammapathy was associated with the hyperproduction of monoclonal ILCs of λ- and κ-type in 14 and 17 patients, respectively. The obtained value was compared with the data of physical examination and laboratory and instrumental studies indicating lesions to target organs and with the course of the disease. Results. In patients with the good course of AL amyloidosis, the average level of free ILCs was 1.8 (range 0.77-3) times greater than the normal values (the range of ILCs of λ and k-type was 20.24 to 67.4 and 20.14 to 81.38 mg/l, respectively); in those with the poor course, the excess of ILCs was 5.8 (range 3.7-13) times higher than the normal values (the range of ILCs of λ and κ-type was 54.32 to 286.7 and 117.06 to 2606.0 mg/l, respectively). The optimal range of diagnostic sensitivity (75%) and specificity (75%) in the estimation of prognosis was determined at the ILC levels that were three times greater (64.5 mg/l for κ-ILCs and 80 mg/l for λ-ILCs). Among the patients with a blood free ILC level of m 3 times more than the normal values, the good and poor courses of AL amyloidosis were noted in 13 and 4 cases, respectively. Conclusion. The determination of serum ILC concentration by the Freelite method may be used to diagnose AL amyloidosis and to specify the presence of appropriate organ dysfunction; this study over time makes it possible to monitor the course of the disease and to estimate its response to therapy.https://ter-arkhiv.ru/0040-3660/article/view/30597amyloidosisimmunoglobulin light chainsnephritic syndromeserum amyloid precursor proteintissue amyloid precursor protein
collection DOAJ
language Russian
format Article
sources DOAJ
author V V Rameyev
L V Kozlovskaya
I N Kogarko
B S Kogarko
spellingShingle V V Rameyev
L V Kozlovskaya
I N Kogarko
B S Kogarko
New capacities of the diagnosis and monitoring of the course of AL-amyloidosis
Терапевтический архив
amyloidosis
immunoglobulin light chains
nephritic syndrome
serum amyloid precursor protein
tissue amyloid precursor protein
author_facet V V Rameyev
L V Kozlovskaya
I N Kogarko
B S Kogarko
author_sort V V Rameyev
title New capacities of the diagnosis and monitoring of the course of AL-amyloidosis
title_short New capacities of the diagnosis and monitoring of the course of AL-amyloidosis
title_full New capacities of the diagnosis and monitoring of the course of AL-amyloidosis
title_fullStr New capacities of the diagnosis and monitoring of the course of AL-amyloidosis
title_full_unstemmed New capacities of the diagnosis and monitoring of the course of AL-amyloidosis
title_sort new capacities of the diagnosis and monitoring of the course of al-amyloidosis
publisher "Consilium Medicum" Publishing house
series Терапевтический архив
issn 0040-3660
2309-5342
publishDate 2010-06-01
description Aim: to define the clinical value of various concentrations of immunoglobulin light chains (ILCs) in patients with AL amyloidosis. Subjects and methods. The content of free ILCs was studied by a nephelometric technique after their fixation in the blood of 31 patients with AL amyloidosis; monoclonal gammapathy was associated with the hyperproduction of monoclonal ILCs of λ- and κ-type in 14 and 17 patients, respectively. The obtained value was compared with the data of physical examination and laboratory and instrumental studies indicating lesions to target organs and with the course of the disease. Results. In patients with the good course of AL amyloidosis, the average level of free ILCs was 1.8 (range 0.77-3) times greater than the normal values (the range of ILCs of λ and k-type was 20.24 to 67.4 and 20.14 to 81.38 mg/l, respectively); in those with the poor course, the excess of ILCs was 5.8 (range 3.7-13) times higher than the normal values (the range of ILCs of λ and κ-type was 54.32 to 286.7 and 117.06 to 2606.0 mg/l, respectively). The optimal range of diagnostic sensitivity (75%) and specificity (75%) in the estimation of prognosis was determined at the ILC levels that were three times greater (64.5 mg/l for κ-ILCs and 80 mg/l for λ-ILCs). Among the patients with a blood free ILC level of m 3 times more than the normal values, the good and poor courses of AL amyloidosis were noted in 13 and 4 cases, respectively. Conclusion. The determination of serum ILC concentration by the Freelite method may be used to diagnose AL amyloidosis and to specify the presence of appropriate organ dysfunction; this study over time makes it possible to monitor the course of the disease and to estimate its response to therapy.
topic amyloidosis
immunoglobulin light chains
nephritic syndrome
serum amyloid precursor protein
tissue amyloid precursor protein
url https://ter-arkhiv.ru/0040-3660/article/view/30597
work_keys_str_mv AT vvrameyev newcapacitiesofthediagnosisandmonitoringofthecourseofalamyloidosis
AT lvkozlovskaya newcapacitiesofthediagnosisandmonitoringofthecourseofalamyloidosis
AT inkogarko newcapacitiesofthediagnosisandmonitoringofthecourseofalamyloidosis
AT bskogarko newcapacitiesofthediagnosisandmonitoringofthecourseofalamyloidosis
_version_ 1724650341917523968